News Headlines

  1. Ajinomoto Bio-Pharma Services Expands Small Molecule Manufacturing Capabilities At Its India Facility 8/13/2020

    Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a major expansion of small molecule manufacturing capabilities with the addition of a new production facility in Visakhapatnam, India.

  2. Catalent Gene Therapy Facility Receives FDA Approval As An Additional Manufacturing Site For AveXis' Gene Therapy 8/6/2020

    Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it was approved by the U.S. Food and Drug Administration (FDA) to produce commercial drug substance intermediate for AveXis’ spinal muscular atrophy (SMA) gene therapy at its manufacturing facility located in Harmans, Maryland.

  3. Pii Is Offering A $100,000 Grant For A First-In-Human Project 8/5/2020

    The pharmaceutical industry appears to be experiencing a shift in resources to more urgent, immediate needs related to the pandemic, leaving emerging biotech companies short on resources to even get through the remainder of the year. At Pii we know that your scaled back projects are more than projects. They are promising therapies and somewhere a patient has planned for your success. That is the reason for this grant!

  4. Sharp Acquires Stake In Berkshire Sterile Manufacturing 8/5/2020

    Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has purchased a minority ownership in Berkshire Sterile Manufacturing (BSM).

  5. Corerx, Inc. Fully Operational In New Product Development Center 8/4/2020

    CoreRx, Inc., a global contract development and manufacturing services company opened its fourth new facility, on the ICOT campus in Clearwater, FL in April 2020.

  6. Lonza Expands Microbial Capacity And Extends Long-Term Partnership With Servier For L-asparaginase API Manufacturing 8/4/2020

    Lonza announced an expansion to the company’s microbial manufacturing facility in Visp, Switzerland. The new facility will provide mid-scale commercial manufacturing to multiple customers and in particular, serve the growing needs of Servier, an independent international pharmaceutical company and long-term Lonza partner.

  7. Catalent Adds Potent Manufacturing Capabilities At Its Buenos Aires, Argentina Site 8/4/2020

    Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing, solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it will expand its Argentinian site in Loma Hermosa, Buenos Aires.

  8. Avid Bioservices And Argonaut Manufacturing Services Enter Agreement To Offer Biotechnology And Pharmaceutical Clients Integrated Process Development, Drug Substance Manufacturing And Drug Product Parenteral Manufacturing 8/3/2020

    Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, and Argonaut Manufacturing Services, a CGMP contract manufacturing organization (CMO) dedicated to providing custom manufacturing and supply chain solutions for life science, molecular diagnostics, and biopharmaceutical companies, today announced a co-marketing agreement that will provide clients an integrated manufacturing solution including process development, drug substance manufacturing, and drug product manufacturing.

  9. Helsinn Advanced Synthesis Opens Its Largest Dedicated Anticancer Bay 7/30/2020

    Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, announces that its manufacturing subsidiary, Helsinn Advanced Synthesis SA (HAS), which develops and manufactures Active Pharmaceutical Ingredients (APIs), cGMP Advanced Intermediates, High Potency APIs (HPAPIs) and anticancer compounds, has opened its largest dedicated Anticancer bay at its manufacturing plant in Biasca, Switzerland.

  10. SARS-CoV-2: IDT Biologika Fills Vaccine Candidate - Clinical Phase About To Begin 7/29/2020

    In the early morning of 24 July IDT Biologika filled the second clinical batch of the newly-developed vaccine candidate against the coronavirus SARS-CoV-2 in Dessau. Now around 1,000 individual vaccine doses with the highest intended dosage level are to be inspected, tested in quality control, labelled and packed before being sent to Hamburg.